4.5 Article

Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia

期刊

HUMAN GENE THERAPY
卷 33, 期 15-16, 页码 801-809

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/hum.2022.005

关键词

congenital adrenal hyperplasia; 21-hydroxylase deficiency; 17 alpha-hydroxylase/1720 lyase deficiency; 11 beta-hydroxylase deficiency; gene therapy; AAV vector; adrenal injection

资金

  1. Japan Society for the Promotion of Science [16K10005, 19K08359]
  2. National Center for Child Health and Development [2019B-11]
  3. Japan Agency for Medical Research and Development [20bm804017h0001]

向作者/读者索取更多资源

Congenital adrenal hyperplasia (CAH) is a genetic disorder caused by enzyme defects. This study investigated the potential of gene induction in the adrenal glands to ameliorate CAH, and found that it may be effective for microsomal P450 defects but may require adrenal gene induction for mitochondrial P450 defects.
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by steroidogenic enzymes containing monogenetic defects. Most steroidogenic enzymes are cytochrome P450 groups that can be categorized as microsomal P450s, including 21-hydroxylase and 17 alpha-hydroxylase/17,20 lyase, and mitochondrial P450s, including 11 beta-hydroxylase. It has been shown that ectopic administration of Cyp21a1 ameliorates steroid metabolism in 21-hydroxylase-deficient mice. However, the effectiveness of this approach for mitochondrial P450 has not yet been evaluated. In this study, primary fibroblasts from patients with 21-hydroxylase deficiency (CYP21A2D) (n=4), 17 alpha-hydroxylase/17,20 lyase deficiency (CYP17A1D) (n=1), and 11 beta-hydroxylase deficiency (CYP11B1D) (n=1) were infected with adeno-associated virus type 2 (AAV2) vectors. Steroidogenic enzymatic activity was not detected in the AAV2-infected CYP11B1D fibroblasts. Induced pluripotent stem cells (iPSCs) of CYP11B1D were established and differentiated into adrenocortical cells by induction of the NR5A1 gene. Adrenocortical cells established from iPSCs of CYP11B1D (CYP11B1D-iPSCs) were infected with an AAV type 9 (AAV9) vector containing CYP11B1 and exhibited 11 beta-hydroxylase activity. For an in vivo evaluation, we knocked out Cyp11b1 in mice by using the CRISPR/Cas9 method. Direct injection of Cyp11b1-containing AAV9 vectors into the adrenal gland of Cyp11b1-deficient mice significantly reduced serum 11-deoxycorticosterone/corticosterone ratios at 4 weeks after injection and the effect was prolonged for up to 12 months. This study indicated that CYP11B1D could be ameliorated by gene induction in the adrenal glands, which suggests that a defective-enzyme-dependent therapeutic strategy for CAH would be required. Defects in microsomal P450, including CYP21A2D and CYP17A1D, can be treated with extra-adrenal gene induction. However, defects in mitochondrial P450, as represented by CYP11B1D, may require adrenal gene induction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据